Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001610717-26-000296 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
60,000
Total Value
$3,737,804.46
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Exercise/Conversion | 20,000 | $18.56 | $371,200.00 | 143,269 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Sale | 4,553 | $167.34 | $761,921.79 | 138,716 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Sale | 9,496 | $168.20 | $1,597,188.27 | 129,220 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Sale | 5,651 | $169.24 | $956,398.41 | 123,569 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Sale | 300 | $170.32 | $51,096.00 | 123,269 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 20,600 | Direct | โ | View Details |